SRTAStrata Critical Medical, Inc.
Is the business good?
The checks split: nothing decisive, though margins widening.
Operating margin has widened over the past few years, the business is getting more profitable per dollar of sales.
Margin-driven, fat margins on slower asset turns. ROE 15% = margin × turnover × leverage.
All from derived.
Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.
How good a business is SRTA?
Strata Critical Medical, Inc. earns −6.3% on the capital it employs against a 9.0% cost of capital, so growth costs more than it returns.
Return on invested capital · cost of capital 9.0% · 15 points below what the capital costs: growth destroys value
- Operating margin
- −8.0%
Operating margin · Medical Care Facilities median 9.3% · 12 months to Q2 2026
- Share count, year on year
- +6.0%
Share count, year on year · shareholders own a smaller slice than a year ago
- Gross margin
- 21%
Gross margin
| Year | Operating margin |
|---|---|
| FY2019 | −44% |
| FY2020 | −48% |
| FY2022 | −37% |
| FY2023 | −30% |
| FY2024 | −15% |
| FY2025 | −11% |
Details›
- Gross margin12 months to Q2 2026
- 21%
- Operating margin12 months to Q2 2026
- −8.0%
- Net margin12 months to Q2 2026
- 16%
- Free cash flow margin
- −19%
- Revenue, trailing twelve months
- $256M
- Free cash flow, trailing twelve months
- −$48M
- Net income, trailing twelve months
- $40M
- Return on invested capitaloperating profit after tax ÷ debt + equity − cash
- −6.3%
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
Medical Care Facilities
Ranks #27 of 27 by RyuScore